Chemical lobotomy
Chemical lobotomy is a phrase people use when a psychiatric medication leaves them feeling emotionally switched off: numb, uninterested, going through the day without much reaching them. It is not a medical diagnosis. The closest clinical names are emotional blunting and SSRI-induced apathy syndrome.
Also called: Chemically lobotomized.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
This page is about the phrase people use for feeling emotionally flat on an antidepressant. A lobotomy was a brain operation, and no medication does anything surgical.
Where does the phrase chemical lobotomy come from?
From surgery. In 1935 the Portuguese neurologist Egas Moniz proposed prefrontal leucotomy, also called lobotomy, a procedure meant to divide the white matter tracts connecting the prefrontal cortex and the thalamus, and from 1936 Walter Freeman and James Watts promoted it and its later version, transorbital lobotomy. People borrow the word because it carries how final the flatness feels, not because any medication cuts anything.
A medication is a different kind of thing: it acts while it is in your body. The apathy reported on SSRIs has been described in the literature as dose-dependent and reversible, and no label uses the phrase chemical lobotomy at all.
Does the numbness go away?
The reports say it eases when the medication behind it changes. A 2004 review in the Journal of Psychiatric Practice describes SSRI apathy syndrome as dose-dependent and reversible. A 2010 paper on SSRI-induced indifference reports complete resolution of symptoms with the discontinuation of the offending drug, and higher SSRI doses as more likely to produce it. Both rest on thin ground: the 2004 review collected twelve case reports and one open-label trial, and the 2010 paper says little is known about this syndrome and that few empirical studies have been done. How often the flatness lifts, and how fast, has not been counted.
Your own timing turns on the dose, the medication and what your depression is doing. The flatness is also not always the drug. In a 2017 survey of 669 treated depressed patients, blunting scores rose along with depression scores, and the authors concluded that emotional blunting is a symptom of depression as well as a side effect of treatment. In the 2022 survey below, 56% of patients put their blunting down to their depression, and a 2023 scoping review of 25 studies found that the literature still does not separate blunting as a symptom of depression from blunting as a drug effect.
Why do people reach for that phrase?
Because the feeling is common and the official paperwork barely names it. In that 2017 survey, 46% of 669 depressed patients on treatment reported emotional blunting, 52% of men and 44% of women. A 2022 survey took 752 patients in Brazil, Canada and Spain who were on a prescribed antidepressant and had already reported emotional blunting in the past 6 weeks. Among them, 45% thought the antidepressant was blunting their emotions, and 39% were considering stopping it, or had already stopped, over emotion-related side effects.
The labels are uneven about it. The Celexa label lists apathy as a frequent psychiatric adverse reaction, meaning it turned up in at least 1 in 100 patients in the trials before approval. On the Lexapro label apathy appears only among post-marketing reports, where no frequency can be worked out, and neither label uses the words emotional blunting anywhere. When the official words are missing, people use their own, and this one carries how heavy it feels.
What should you do if you feel chemically lobotomized?
Use those words with your prescriber if that is how it feels, then give them something to work with: when it started, what dose you were on, and whether anything still gets through. The 2010 paper lists the options a prescriber weighs, which are a lower dose, a second medication added, or a move off the SSRI to another kind of antidepressant. In the 2023 review of 25 studies, the two moves that came up most in practice were a lower dose and a switch to a different antidepressant.
Do not make the change alone. NIMH says people should not stop a prescribed medication, even if they are feeling better, without the help of a health care provider, who can adjust the plan and bring the dose down slowly and safely. The MedlinePlus page for escitalopram says the same drug by drug: do not stop it without talking to your doctor, and the dose will probably be decreased gradually. Tell your doctor right away about new or worsening depression.
What to do
Take what you noticed to your prescriber: when the flatness started, the dose you were on then, and one thing each day that still got through to you, however small. Ask whether a lower dose, an add-on or a different antidepressant is worth trying in your case, and what the trade-off would be for your depression. If your mood drops or you have thoughts of harming yourself, call or text 988 in the US, or your local emergency number.
Read the guide to emotional blunting
How withClaro helps
- Log how much you feel each day, next to your dose
- See whether it began with a dose change
- Share a PDF report with your prescriber
Get the withClaro app on the App Store
Related terms
Sources
- Lichterman BL, Schulder M, Liu B, Yang X, Taira T. A comparative history of psychosurgery. Progress in Brain Research, 2022.
- Barnhart WJ, Makela EH, Latocha MJ. Selective serotonin reuptake inhibitor-induced apathy syndrome: a clinical review. Journal of Psychiatric Practice, 2004.
- Sansone RA, Sansone LA. SSRI-induced indifference. Psychiatry (Edgmont), 2010.
- Goodwin GM, Price J, De Bodinat C, Laredo J. Emotional blunting with antidepressant treatments: a survey among depressed patients. Journal of Affective Disorders, 2017.
- Christensen MC, Ren H, Fagiolini A. Emotional blunting in patients with depression. Part I: clinical characteristics. Annals of General Psychiatry, 2022.
- Jawad MY, Fatima M, Hassan U, Zaheer Z, Ayyan M, Ehsan M, Khan MHA, Qadeer A, Gull AR, Asif MT, Shad MU. Can antidepressant use be associated with emotional blunting in a subset of patients with depression? A scoping review of available literature. Human Psychopharmacology, 2023.
- U.S. Food and Drug Administration. Celexa (citalopram): prescribing information. FDA / DailyMed, 2023.
- U.S. Food and Drug Administration. Lexapro (escitalopram) tablets and oral solution: prescribing information. FDA / DailyMed, 2026.
- U.S. National Library of Medicine. Escitalopram. MedlinePlus, 2025.
- National Institute of Mental Health (NIMH). Mental Health Medications. NIMH, 2024.
All glossary terms